An investigation on behalf of investors in United Therapeutics Corporation (NASDAQ:UTHR) shares over potential wrongdoing at United Therapeutics was announced and NASDAQ:UTHR stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/10/2016 -- An investigation on behalf of investors in shares of United Therapeutics Corporation was announced over potential breaches of fiduciary duties by certain officers and directors at United Therapeutics.
Investors who purchased shares of United Therapeutics Corporation (NASDAQ:UTHR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain United Therapeutics officers and directors breached their fiduciary duties.
United Therapeutics Corporation reported that its annual Total Revenue rose from over $1.28 billion in 2014 to over $1.46 billion in 2015 and that its Net Income increased from $340.07 million in 2014 to $651.64 million in 2015. Shares of United Therapeutics Corporation (NASDAQ:UTHR) declined from as high as $188.15 per share in June 2015 to as low as $98.33 per share in June 27, 2016.
On November 9, 2016, NASDAQ:UTHR shares closed at $129.98 per share.
Those who purchased shares of United Therapeutics Corporation have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com